Reika Wate
Affiliations: | Neurology | Kansai Medical University, Hirakata-shi, Ōsaka-fu, Japan |
Google:
"Reika Wate"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Itani K, Nakamura M, Wate R, et al. (2021) Efficacy and safety of tacrolimus as long-term monotherapy for myasthenia gravis. Neuromuscular Disorders : Nmd |
| Ayaki T, Ito H, Komure O, et al. (2017) Multiple Proteinopathies in Familial ALS Cases With Optineurin Mutations. Journal of Neuropathology and Experimental Neurology |
| Oki M, Kaneko S, Morise S, et al. (2017) Zonisamide ameliorates levodopa-induced dyskinesia and reduces expression of striatal genes in Parkinson model rats. Neuroscience Research |
| Tsuge A, Kaneko S, Wate R, et al. (2017) Weight loss in the early stage of progressive supranuclear palsy. Brain and Behavior. 7: e00616 |
| Itani K, Wate R, Kaneko S, et al. (2017) Long-term efficacy and safety of tacrolimus monotherapy for myasthenia gravis Journal of the Neurological Sciences. 381: 467 |
| Oki M, Hori S, Asayama S, et al. (2016) Early-onset Parkinson's Disease Associated with Chromosome 22q11.2 Deletion Syndrome. Internal Medicine (Tokyo, Japan). 55: 303-5 |
| Iida S, Nakamura M, Wate R, et al. (2015) Successful treatment of paroxysmal tonic spasms with topiramate in a patient with neuromyelitis optica. Multiple Sclerosis and Related Disorders. 4: 457-9 |
| Nakamura S, Wate R, Kaneko S, et al. (2014) An autopsy case of sporadic amyotrophic lateral sclerosis associated with the I113T SOD1 mutation. Neuropathology : Official Journal of the Japanese Society of Neuropathology. 34: 58-63 |
| Asayama S, Wate R, Kaneko S, et al. (2013) Levodopa challenge test and (123) I-metaiodobenzylguanidine scintigraphy for diagnosing Parkinson's disease. Acta Neurologica Scandinavica. 128: 160-5 |
| Nakamura M, Kaneko S, Ito H, et al. (2013) Activation of transforming growth factor-β/Smad signaling reduces aggregate formation of mislocalized TAR DNA-binding protein-43. Neuro-Degenerative Diseases. 11: 182-93 |